Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP343988.RAKSa6voV0qR8daDJ0D9j_ZejRKUu6BuyHx7VXZA-HZ68130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP343988.RAKSa6voV0qR8daDJ0D9j_ZejRKUu6BuyHx7VXZA-HZ68130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP343988.RAKSa6voV0qR8daDJ0D9j_ZejRKUu6BuyHx7VXZA-HZ68130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP343988.RAKSa6voV0qR8daDJ0D9j_ZejRKUu6BuyHx7VXZA-HZ68130_provenance.
- NP343988.RAKSa6voV0qR8daDJ0D9j_ZejRKUu6BuyHx7VXZA-HZ68130_assertion description "[However, the expression pattern of FOXP1 in normal breast tissue is more reminiscent of the second receptor, ERbeta, which has an emerging role as a tumour suppressor in breast cancer and critically may underlie the ability of some ERalpha-negative tumours to respond to tamoxifen.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP343988.RAKSa6voV0qR8daDJ0D9j_ZejRKUu6BuyHx7VXZA-HZ68130_provenance.
- NP343988.RAKSa6voV0qR8daDJ0D9j_ZejRKUu6BuyHx7VXZA-HZ68130_assertion evidence source_evidence_literature NP343988.RAKSa6voV0qR8daDJ0D9j_ZejRKUu6BuyHx7VXZA-HZ68130_provenance.
- NP343988.RAKSa6voV0qR8daDJ0D9j_ZejRKUu6BuyHx7VXZA-HZ68130_assertion SIO_000772 18026833 NP343988.RAKSa6voV0qR8daDJ0D9j_ZejRKUu6BuyHx7VXZA-HZ68130_provenance.
- NP343988.RAKSa6voV0qR8daDJ0D9j_ZejRKUu6BuyHx7VXZA-HZ68130_assertion wasDerivedFrom befree-20140225 NP343988.RAKSa6voV0qR8daDJ0D9j_ZejRKUu6BuyHx7VXZA-HZ68130_provenance.
- NP343988.RAKSa6voV0qR8daDJ0D9j_ZejRKUu6BuyHx7VXZA-HZ68130_assertion wasGeneratedBy ECO_0000203 NP343988.RAKSa6voV0qR8daDJ0D9j_ZejRKUu6BuyHx7VXZA-HZ68130_provenance.
- befree-20140225 importedOn "2014-02-25" NP343988.RAKSa6voV0qR8daDJ0D9j_ZejRKUu6BuyHx7VXZA-HZ68130_provenance.